What researchers published on Áttétes emlőrák
3845 papers, newest first.
Showing 20 of 3845
Not labelled yetCost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
Not labelled yetPalbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
Not labelled yetEffect of different axillary management strategies on survival in elderly patients (≥70 Years) with early-stage breast cancer and 1-2 positive lymph nodes, stratified by risk factors.PloS one
Not labelled yetHigh-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling.Analytical chemistry
Not labelled yetPotential prognostic value of the free T3/T4 ratio in HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.BMC cancer
Not labelled yetInterpreting EORTC CAT Core short-form scores in metastatic breast cancer: EQ-VAS-associated cut-points and comparison with published thresholds for clinical importance.Journal of patient-reported outcomes
Not labelled yetAnalytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib.Translational oncology
Not labelled yetCD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Not labelled yetReal-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study.Breast cancer (Tokyo, Japan)
EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
Not labelled yetDual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou.Breast cancer (Dove Medical Press)
EsetismertetésSequential Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapy and Late-Line Tucatinib in Patients With HER2-Positive Breast Cancer and Brain Metastases: A Real-World Case Report.Cureus
Not labelled yetTP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
ÁttekintésMechanotransduction in breast cancer and implications for preclinical modeling.Cancer metastasis reviews
Not labelled yetFOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon.BMC cancer
EsetismertetésExperience with pyrotinib monotherapy for advanced HER2-positive breast cancer with diffuse hepatic metastases and severe hepatic dysfunction: a case report.International journal of surgery case reports
ÁttekintésMitochondrial Calcium Signaling Acts in the Regulation of Quiescence in Estrogen Receptor-Positive Breast Cancer.The Yale journal of biology and medicine
Not labelled yetGlycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer.Signal transduction and targeted therapy
MetaanalízisSequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.European journal of clinical pharmacology
Not labelled yetMolecular and clinical predictors of NAC response and relapse in HR+/HER2- early breast cancer.Breast cancer research : BCR